Dr. Anita Ravipati
Claim this profileThe Don and Sybil Harrington Cancer Center
Expert in Lung Cancer
Studies Non-Small Cell Lung Cancer
30 reported clinical trials
56 drugs studied
About Anita Ravipati
Education:
- Earned a Medical degree (MD) from an accredited medical school.
- Completed Residency in Internal Medicine at Texas Tech University Health Sciences Center.
- Undertook a Fellowship in Hematology/Oncology at The Don and Sybil Harrington Cancer Center, part of Texas Tech University Health Sciences Center.
Experience:
- Currently practicing as a hematologist and oncologist at The Don and Sybil Harrington Cancer Center.
Area of expertise
1Lung Cancer
Global LeaderStage IV
Stage III
Stage II
2Non-Small Cell Lung Cancer
Stage IV
RET positive
Stage III
Affiliated Hospitals
Clinical Trials Anita Ravipati is currently running
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
APL-101
for Lung Cancer
This trial is testing APL-101, a new drug, on patients with specific genetic changes in their cancer. These patients often don't respond to typical treatments. The drug aims to block a protein that helps cancer cells grow and spread.
Recruiting1 award Phase 211 criteria
More about Anita Ravipati
Clinical Trial Related2 years of experience running clinical trials · Led 30 trials as a Principal Investigator · 13 Active Clinical TrialsTreatments Anita Ravipati has experience with
- Pembrolizumab
- Nivolumab
- Biospecimen Collection
- Cisplatin
- Oxaliplatin
- Ramucirumab
Breakdown of trials Anita Ravipati has run
Lung Cancer
Non-Small Cell Lung Cancer
Breast Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Anita Ravipati specialize in?
Anita Ravipati focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is Anita Ravipati currently recruiting for clinical trials?
Yes, Anita Ravipati is currently recruiting for 13 clinical trials in Amarillo Texas. If you're interested in participating, you should apply.
Are there any treatments that Anita Ravipati has studied deeply?
Yes, Anita Ravipati has studied treatments such as Pembrolizumab, Nivolumab, Biospecimen Collection.
What is the best way to schedule an appointment with Anita Ravipati?
Apply for one of the trials that Anita Ravipati is conducting.
What is the office address of Anita Ravipati?
The office of Anita Ravipati is located at: The Don and Sybil Harrington Cancer Center, Amarillo, Texas 79106 United States. This is the address for their practice at the The Don and Sybil Harrington Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.